2011
DOI: 10.1016/j.brainres.2011.09.056
|View full text |Cite
|
Sign up to set email alerts
|

Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
21
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 51 publications
(28 citation statements)
references
References 61 publications
7
21
0
Order By: Relevance
“…Consistent with these results, in our laboratory, we found that insufficient inhibitory GSK3β control in STZ-icv rats was demonstrated by a decrease in p-GSK3β levels in the hippocampus, which was associated to STM and LTM impairment (38). Additionally, lithium (GSK3 inhibitor) and pioglitazone (insulin sensitizer) treatment reversed this memory deficit and restored the inhibitory activity of GSK3β in hippocampus [38]. Similarly, other studies have demonstrated that specific inhibition GSK3 activity by lithium prevents hyperphosphorylation of tau, and spatial memory loss resulting from inhibiting the PI3K and PKC [67].…”
Section: Discussionsupporting
confidence: 85%
See 3 more Smart Citations
“…Consistent with these results, in our laboratory, we found that insufficient inhibitory GSK3β control in STZ-icv rats was demonstrated by a decrease in p-GSK3β levels in the hippocampus, which was associated to STM and LTM impairment (38). Additionally, lithium (GSK3 inhibitor) and pioglitazone (insulin sensitizer) treatment reversed this memory deficit and restored the inhibitory activity of GSK3β in hippocampus [38]. Similarly, other studies have demonstrated that specific inhibition GSK3 activity by lithium prevents hyperphosphorylation of tau, and spatial memory loss resulting from inhibiting the PI3K and PKC [67].…”
Section: Discussionsupporting
confidence: 85%
“…Our results showed decrease in p-GSK3β and p-GSK3β/total GSK3β ratio; this indirectly suggested an increase in the active GSK3β form, therefore, this might explain the consequent increase of p-tau. Consistent with these results, in our laboratory, we found that insufficient inhibitory GSK3β control in STZ-icv rats was demonstrated by a decrease in p-GSK3β levels in the hippocampus, which was associated to STM and LTM impairment (38). Additionally, lithium (GSK3 inhibitor) and pioglitazone (insulin sensitizer) treatment reversed this memory deficit and restored the inhibitory activity of GSK3β in hippocampus [38].…”
Section: Discussionsupporting
confidence: 77%
See 2 more Smart Citations
“…In line with these similarities in the pathophysiological background, testing of the therapeutic potential of memantine in the STZ-icv rat model revealed that the memory impairment induced by 3 mg/kg STZ-icv dose in rats was successfully reversed by a 2-week memantine treatment with a 5 mg/kg i.p. dose (Ponce-Lopez et al 2011). However, the memory functions were tested by food magazine and autoshaping training while there is no data on spatial memory in the Morris Water Maze test.…”
Section: Nmda Receptor Antagonistsmentioning
confidence: 99%